Role of Hypothalamic Melanocortin System in Adaptation of Food Intake to Food Protein Increase in Mice
暂无分享,去创建一个
S. Luquet | B. Pillot | G. Mithieux | C. Magnan | D. Naville | A. Gautier-Stein | M. Bégeot | I. Houberdon | A. Joly | M. Vigier | C. Duraffourd | Céline Duraffourd
[1] W. Millard,et al. Implication of the melanocortin-3 receptor in the regulation of food intake. , 2011, European journal of pharmacology.
[2] F. Delaere,et al. Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity. , 2010, Diabetes & metabolism.
[3] G. Mithieux,et al. Metabolic and melanocortin gene expression alterations in male offspring of obese mice , 2010, Molecular and Cellular Endocrinology.
[4] B. Pillot,et al. Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin. , 2009, Endocrinology.
[5] G. Mithieux,et al. Leptin Infusion and Obesity in Mouse Cause Alterations in the Hypothalamic Melanocortin System , 2008, Obesity.
[6] P. Barrett,et al. Solid and liquid obesogenic diets induce obesity and counter-regulatory changes in hypothalamic gene expression in juvenile Sprague-Dawley rats. , 2007, The Journal of nutrition.
[7] R. Palmiter,et al. NPY/AgRP neurons are not essential for feeding responses to glucoprivation , 2007, Peptides.
[8] M. Lutter,et al. Molecular determinants of energy homeostasis. , 2006, The American journal of psychiatry.
[9] Robert A. McGovern,et al. Divergence of Melanocortin Pathways in the Control of Food Intake and Energy Expenditure , 2005, Cell.
[10] P. Misery,et al. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. , 2005, Cell metabolism.
[11] R. Palmiter,et al. NPY/AgRP Neurons Are Essential for Feeding in Adult Mice but Can Be Ablated in Neonates , 2005, Science.
[12] G. Mithieux. The new functions of the gut in the control of glucose homeostasis , 2005, Current opinion in clinical nutrition and metabolic care.
[13] Stephen R. Bloom,et al. The inhibitory effects of peripheral administration of peptide YY3–36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal–brainstem–hypothalamic pathway , 2005, Brain Research.
[14] K. Toshinai,et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. , 2005, Endocrinology.
[15] F. Nuttall,et al. Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. , 2004, Diabetes.
[16] D. Macneil,et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. , 2004, Endocrinology.
[17] J Dixon,et al. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Flier. Obesity Wars Molecular Progress Confronts an Expanding Epidemic , 2004, Cell.
[19] A. G. Roseberry,et al. Transgenic Mice Expressing Green Fluorescent Protein under the Control of the Melanocortin-4 Receptor Promoter , 2003, The Journal of Neuroscience.
[20] E. Air,et al. The Catabolic Action of Insulin in the Brain Is Mediated by Melanocortins , 2002, The Journal of Neuroscience.
[21] M. Schwartz,et al. Obesity: Keeping hunger at bay , 2002, Nature.
[22] Rachel L. Batterham,et al. Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.
[23] L. Storlien,et al. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. , 2002, American journal of physiology. Endocrinology and metabolism.
[24] T. Moran,et al. Cholecystokinin and satiety: current perspectives. , 2000, Nutrition.
[25] J. Friedman,et al. Obesity in the new millennium , 2000, Nature.
[26] K. Clément,et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. , 2000, The Journal of clinical investigation.
[27] M. Nakazato,et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.
[28] G. Barsh,et al. Effects of recombinant agouti-signaling protein on melanocortin action. , 1997, Molecular endocrinology.
[29] R. Cone,et al. Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.
[30] W. Banks,et al. Leptin enters the brain by a saturable system independent of insulin , 1996, Peptides.
[31] S. Watson,et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. , 1993, The Journal of biological chemistry.
[32] E. Kraegen,et al. Development of Muscle Insulin Resistance After Liver Insulin Resistance in High-Fat–Fed Rats , 1991, Diabetes.
[33] S. Rössner,et al. Effects of a high-protein meal (meat) and a high-carbohydrate meal (vegetarian) on satiety measured by automated computerized monitoring of subsequent food intake, motivation to eat and food preferences. , 1990, International journal of obesity.
[34] B. Rolls,et al. The specificity of satiety: The influence of foods of different macronutrient content on the development of satiety , 1988, Physiology & Behavior.
[35] G. P. Smith,et al. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. , 1981, Science.
[36] D. Booth,et al. Subcutaneous dialysis in the study of the effects of nutrients on feeding. , 1970, Physiology & behavior.
[37] G. Mithieux,et al. Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet. , 2002, Diabetes.